A Phase II Study of Glembatumumab Vedotin for Metastatic Uveal Melanoma

by Merve Hasanov, Matthew J. Rioth, Kari Kendra, Leonel Hernandez-Aya, Richard W. Joseph, Stephen Williamson, Sunandana Chandra, Keisuke Shirai, Christopher D. Turner, Karl Lewis, Elizabeth Crowley, Jeffrey Moscow, Brett Carter, Sapna Patel
Published 2020-08-01